(R) -Elsubrutinib
(R) -Elsubrutinib ((R) -ABBV-105) is a Btk inhibitor. (R) -Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer[1].
Product Specifications
CAS Number
1643570-23-3
Product Name Alternative
(R) -ABBV-105
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/r-elsubrutinib.html
Purity
98.0
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC=C([C@@H]2CN(C(C=C)=O)CCC2)C3=C1NC=C3)N
Molecular Formula
C17H19N3O2
Molecular Weight
297.35
References & Citations
[1]Dominique Bonafoux, et al. Primary carboxamides as Btk inhibitors. Patent WO2014210255Al.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mucin 5AC (MUC5AC) (45M1), CF405S conjugate, 0.1mg/mL
Fibronectin (TV-1), CF740 conjugate, 0.1mg/mL
